A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
Stretching Your Dollars: Financial Tips for Savvy Homebuyers 
With home sales rising 4.1 percent in April from the month before and 11.8 percent from a year ago, the housing market is still hot. Kirsten Jordan, associate real estate broker for Douglas Elliman, has some tips to help savvy homebuyers get into the market
Elizabeth Holmes Begins 11-Year Sentence for Blood-Testing Hoax
Disgraced Theranos CEO Elizabeth Holmes is in custody at a Texas prison where she could spend the next 11 years for overseeing a blood-testing hoax that became a parable about greed and hubris in Silicon Valley, according to the Federal Bureau of Prisons.
Load More